DURHAM, NC, March 12, 2013 (Press-News.org) MobileSmith, a leading provider of mobile software solutions for enterprise customers, and TVAR Solutions, a value-added reseller of cloud and mobile infrastructure to the US government, announced a strategic partnership to deliver innovative mobile solutions to Federal agencies.
"With TVAR's 20 years of experience delivering cloud IT solutions to the government, MobileSmith can now empower more Federal clients to quickly and cost-effectively build, deploy, and manage secure mobile applications for both iOS and Android devices," said Bob Dieterle, Senior VP and General Manager of MobileSmith.
"Enterprise applications are moving from PC's to mobile devices. MobileSmith accelerates this transition through its ease of use and flexible deployment strategy. Government will be able to deliver services to more Americans in more ways using mobile apps based on MobileSmith," - said Toby Zellers, Vice President of Strategy and Solutions, TVAR Solutions.
MobileSmith is a complete cloud solution for enterprise mobility and a patent-pending SaaS platform that allows creating and deploying custom native mobile apps without writing a line of code. The platform also serves as a back-office for secure management of your organization's entire portfolio of apps; pushing real-time notifications, and easy updating of apps without re-submitting them to the app stores. MobileSmith and TVAR experts provide comprehensive mobile strategy consulting and secure integration of your mobile apps portfolio with your back-end systems.
MobileSmith and TVAR will offer a joint educational webinar: "Agility, Centralization, and Cost Control in Delivering Federal Mobile Applications" on Wednesday, April 10, 2 pm. To register, visit: http://www.mobilesmith.com/webinar-federal-mobile-apps/
MobileSmith is a brand of Smart Online, Inc. (OTCBB: SOLN), a leading provider of cutting-edge mobile software solutions. We empower our customers to get to market quickly with self-built mobile apps that drive business value. Our patents pending MobileSmith platform is an innovative cloud solution that enables organizations to rapidly create, deploy, manage and update custom, native Smartphone apps deliverable across iPhone and Android platforms. With no prior knowledge of software programming, business managers can quickly and affordably take their company mobile.
For more information, visit www.MobileSmith.com
TVAR Solutions is a value-added reseller that can design, deploy, and manage effective infrastructure, from data centers to cloud to mobile devices. Our senior technical advisors, experienced engineers, and proven performance ensure a fully functional, dynamic, and secure enterprise. TVAR Solutions has the people who make Federal IT simple. For more information, visit www.TVARsolutions.com
MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal Agencies
TVAR Solutions will help bring MobileSmith's unique cloud technology for quick development, deployment, and management of native smartphone and tablet apps to clients in Federal government.
2013-03-12
ELSE PRESS RELEASES FROM THIS DATE:
CyberlinkASP Completes SSAE 16 SOC 1 Audit Across Datacenter Footprint
2013-03-12
CyberlinkASP, the leader in hosted virtual desktop and private cloud solutions, today announced the completion of the company's annual SSAE 16 SOC 1 audit. CyberlinkASP enlisted an outside accounting firm and subjected itself to a rigorous third party review of all infrastructure, personnel, policies and procedures across its Dallas, Chicago and London facilities.
"This has been a major initiative for us the past few years as more and more firms require documented security policies and procedures relating to IT. We feel it's a must for anyone hosting or managing ...
Laura Wellington: "The Four-Star Diet" Sells Out on Amazon Leading to Invitations From "All-Star" Talk Shows
2013-03-12
No doubt, the media tour for the author of "The Four-Star Diet: Based Upon The Wisdom Of General Colin Powell & Other Ridiculously Brilliant Leaders" has only just begun. Explosive sales on Amazon and similar retailers have made it nearly impossible to get your hands on a print version of the book. With the demand continuing to rise to an already "sell out" crowd, Author Laura J. Wellington has received invitations to appear on numerous "Celebrity, Style, and News" shows from as far away as the UAE. She will begin to make those appearances ...
Rush scientists identify buphenyl as a possible drug for Alzheimer's disease
2013-03-11
(CHICAGO) – Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.
Hyperammonemia is a life-threatening condition that can affect patients at any age. It is caused by abnormal, high levels of ammonia in the blood.
Studies in mice with Alzheimer's disease (AD) have shown that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth and protects learning and memory, according to neurological researchers at the Rush University Medical Center.
Results from ...
Shock teams and ECMO save lives in massive STEMI
2013-03-11
MINNEAPOLIS, MN - March 9, 2013 - The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the American College of Cardiology Scientific Sessions.
ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia (TH) use within a STEMI Network.
"For many patients who present with ...
Niacin therapy shows no benefits, has some harmful effects
2013-03-11
SAN FRANCISCO (March 9, 2013) — A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Detailed trial data is presented here for the first time.
Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) is the largest-ever study of niacin, commonly used to raise ...
Drug protects against kidney injury from imaging dye in ACS patients
2013-03-11
SAN FRANCISCO (March 10, 2013) —High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests.
Previous studies have demonstrated the kidney-protective value of various statins administered before patients undergo ...
Encouraging early results for redesigned Sapien valve
2013-03-11
SAN FRANCISCO (March 10, 2013) — The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
PARTNER II is the first randomized clinical trial involving the Sapien XT valve and the only one that compares the new device to the original FDA-approved Sapien ...
New biolimus stent equal to everolimus stent at 1 year
2013-03-11
SAN FRANCISCO (March 10, 2013) — In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Drug-eluting stents are structures placed inside narrowed coronary arteries to restore proper blood flow. A polymer coating on these devices slowly releases a drug designed to prevent restenosis—another blockage at the same site—and prevent a second ...
Fewer adverse events with 'double kissing' crush stent than culotte
2013-03-11
SAN FRANCISCO (March 10, 2013) — Patients with a type of coronary lesion linked with poor prognosis fared significantly better with the stent technique known as double kissing crush than with culotte stenting, according to data from the DKCRUSH-III trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
DKCRUSH-III is the first head-to-head comparison of double kissing (DK) crush and culotte stent techniques in coronary artery disease. The study focused on bifurcation lesions, which involve a main branch and a smaller side branch ...
Cangrelor superior to clopidogrel in CHAMPION PHOENIX trial
2013-03-11
SAN FRANCISCO (March 10, 2013) — The experimental anti-clotting drug cangrelor solidly outperformed commonly used clopidogrel in a large global trial of patients who underwent coronary stent procedures, according to data from the phase III CHAMPION PHOENIX study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Cangrelor and clopidogrel interfere with the P2Y12 receptor, a platelet-surface protein that helps regulate blood clotting. Currently approved drugs in this class are effective in cutting down ischemic events—blood-flow reductions ...
LAST 30 PRESS RELEASES:
Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training
Day-long conference addresses difficult to diagnose lung disease
First-ever cardiogenic shock academy features simulation lab
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
[Press-News.org] MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal AgenciesTVAR Solutions will help bring MobileSmith's unique cloud technology for quick development, deployment, and management of native smartphone and tablet apps to clients in Federal government.